Menu

AG Wintergerst

Portrait von Herrn Maximilian Wintergerst

Priv.-Doz. Dr. med. Maximilian W. M. Wintergerst, FEBO

Research areas

PD Dr. Wintergerst’s research group is dedicated to exploring innovative ophthalmic imaging approaches and their applications for international ophthalmology and uveitis. Dr. Wintergerst has published over 93 scientific papers (thereof 37 first- / last-authorships) and raised more than 2.000.000 € in funding. Among different international projects that he is heading, he is director of the Hospital Partnership Program of the University Hospital Bonn and the Sankara Eye Hospital Bangalore, India.

Dr. Wintergerst’s interest in imaging methods and image analysis began with his doctoral thesis in basic immunological science where he established a novel imaging and analysis method for cell culture at LMU Munich. Continuing this interest, he established his research focus in ophthalmic imaging and image analysis at University Hospital Bonn and completed his habilitation thesis on the evaluation of Smartphone-based retinal imaging for ophthalmologic examination at the University of Bonn.

The Wintergerst Research Group at University Hospital Bonn develops and evaluates innovative approaches at the intersection of ophthalmic imaging, artificial intelligence, and global eye health. Our research combines clinical studies, quantitative image analysis, and international collaborations to advance the diagnosis, monitoring, and treatment of eye diseases. Our work focuses on three complementary research areas.

Innovative Imaging & Uveitis

Uveitis comprises a heterogeneous group of inflammatory eye diseases that can cause severe visual impairment, often affecting patients of working age. Reliable assessment of intraocular inflammation remains challenging, as many established clinical grading methods are subjective and insufficiently reproducible. This also limits the availability of robust outcome measures for clinical trials.
Our research group focuses on developing and validating objective, quantitative imaging biomarkers for the diagnosis, monitoring, and prognostic assessment of uveitis. We investigate advanced non-invasive imaging technologies, including optical coherence tomography (OCT), OCT angiography (OCT-A), high-resolution OCT, multimodal fundus autofluorescence, and standardized slit-lamp photography.
Our studies have demonstrated the potential of OCT-A-derived retinal vessel density as a prognostic biomarker in intermediate uveitis, showing associations with subsequent visual acuity and retinal thickness. In posterior uveitis, we have investigated spectrally resolved and multi-wavelength fundus autofluorescence for improved characterization of inflammatory chorioretinal lesions. More recently, our group demonstrated high reproducibility of quantitative lesion measurements across different autofluorescence modalities, supporting their potential use as structural endpoints in clinical studies.
Additional research focuses on longitudinal imaging biomarkers, automated image analysis, and standardized documentation of intraocular inflammatory cells using novel imaging approaches.
By combining clinical ophthalmology, advanced imaging, and quantitative analysis, we aim to establish reliable and clinically meaningful biomarkers that improve disease monitoring, support treatment decisions, and facilitate future interventional trials in uveitis.

Focus on finding reliable endpoints to quantify intraocular inflammation using novel imaging techniques and automated image analysis

 

  • Establishment of new qualitative and quantitative prognostic biomarkers for uveitis intermedia, posterior and panuveitis

 

  • Validation of objectifiable readouts for intraocular inflammation suitable as a structural clinical endpoint for intervention studies

 

  • Multimodal approach using non-invasive imaging methods

 

    • OCT-Angiography
      • enables high-resolution visualization of retinal and choriocapillary perfusion and analysis of the effects of inflammation on the microcirculation

 

    • Anterion -OCT
      • enables high-resolution visualization of the anterior segment - currently we’re probing the device for imaging of inflammatory cells in the anterior chamber and anterior vitreous

 

    • Multimodal Fundusautofluorescence (FAF)
      • promising approach in the diagnosis and monitoring of posterior uveitis and panuveitis, as changes in the FAF can be used to assess disease activity not visible by funduscopy or conventional color fundus photography

 

    • Slit-Lamp Imaging
      • color photography represents an optimal interface between conventional slit-lamp examination and novel imaging methods

Global Eye Care & Telemedicine

Limited access to ophthalmologists and conventional imaging equipment remains a major barrier to preventing avoidable visual impairment, particularly in low- and middle-income countries. Our research group develops and evaluates affordable, smartphone-based retinal imaging and teleophthalmology approaches to improve access to eye care in underserved populations.
A particular focus is the implementation of telemedical diabetic retinopathy screening. Our clinical studies have demonstrated the feasibility of smartphone-based retinal imaging in India together with our partner the Sankara Eye Foundation, India, and shown that appropriately trained ophthalmic assistants can acquire retinal images of comparable quality to those obtained by ophthalmologists. We have established international research collaborations and screening initiatives with partners in India, Bangladesh, Nigeria, and Ghana.
Our research extends beyond technical feasibility to address the practical requirements of sustainable screening programmes, including training of local healthcare personnel, AI-assisted image assessment, referral pathways, scalability, and long-term integration into existing healthcare systems.
Our group also led an international expert collaboration resulting in a comprehensive review of 30 smartphone-based fundus imaging systems, published in Progress in Retinal and Eye Research (2026). This work provides an evidence-based assessment of the opportunities, limitations, and future directions of smartphone-based retinal imaging in global eye care.

Smartphone-based fundus imaging (SBFI)

SBFI can be widely used for the detection of several eye diseases of the fundus with the help of medical assistants, who transfer captured images to telemedic grading centers. This method brings out its benefit in underserved rural or urban areas, where it improves the eye care access and lowers the barrier for less privileged populations to undergo a medical examination. The main focus of our SBFI approach as of right know is Diabetic retinopathy (DR). An extension of this screening towards glaucoma, retinopathy of the premature, and other retinal diseases is planned and its feasibility has been shown.

 

Bild einer Augenuntersuchung

 

Artificial intelligence (AI)

In collaboration with Microsoft and the Sankara Eye Foundation in Bangalore, India, we are developing artificial intelligence algorithms with a low-cost approach in association with smartphone-based image capturing in order to improve cataract surgery outcomes in LMIC with the help of AI powered direct response teaching systems. Additionally, in cooperation with the University of Maastricht, the University of Bonn computing department, and the Sankara Eye Foundation, we are developing AI algorithm for automated retinal imaging analysis, which allow to support grading ophthalmologist to improve the efficacy, as well as It gives the opportunity of immediate orientating diagnostic response for patients in screening areas, where no doctor is present. The feasibility for Diabetic retinopathy as well as glaucoma screening has been demonstrated.

 

The simplicity of SBFI

The SBFI principle of scaling is to teach medical aid personnel in SBFI with the help either of an e-Learning class based on the University of Bonn e-learning platform, which can be hosted locally on each project partners server and has shown good results in medical aid personnel teaching. Alternatively, in-person teaching is employed, where local doctors are instructed in SBFI to disseminate knowledge locally to their medical aid personnel. These personnel then conduct screening camps in hard-to-reach rural or urban areas without proper medical healthcare service access.

Medical assistants then captures images in vision camps using SBFI, which are then uploaded into the digital patient health record app. Within this app, results can be retrieved and telemedic doctors can grade those captured images.

Patients finally get results in which time period they may need a checkup or whether they should travel to the closest hospital for treatment if necessary.

 

International Collaboration Partners

We are proud of our cooperation with several namely institutions worldwide mainly in Low - middle Income Countries (LMIC).

India

Since 2016, we have successfully partnered with the Sankara Eye Hospital in Bangalore and the Sankara Eye Foundation, led by Dr. Kaushik, in telemedical smartphone-based DR Screening. Together, we have established several vision camps, as well as our the Sudarshan Eye Sight app. Presently, we are continuing this work and have extended our collaboration to our new cataract surgery improvement project.

 

Bangladesh

For several years, the ORCD Bangladesh, an organization dedicated to rural development and the University of Bonn have collaborated on several projects to enhance eye health in Bangladesh. Starting in 2022, we initiated the implementation of our SBFI approach in Bangladesh to further improve access to eye healthcare in Bangladesh.

 

Nigeria

Since 2022, we have started our Collaboration with the University of Calabar Teaching Hospital in Nigeria, where we are currently jointly establishing a SBFI DR Screening approach.

 

Ghana

Additionally, since 2022, we have begun a partnership with the University of Cape Coast in Ghana, where we have so far dedicated our work towards research on the adaptability of our SBFI approach to different smartphones. We aim to broaden our approach here and implement regular DR screenings based on our collaboratively established SBFI approach.

Artificial Intelligence in Cataract Surgery

Cataract remains one of the leading causes of blindness worldwide, and improving the quality and accessibility of cataract surgery is particularly important in resource-limited settings. In collaboration with the Department of Computer Science at the University of Bonn, Sankara Eye Hospital in India, and Microsoft Research India, our research group develops artificial intelligence methods for the automated analysis of cataract surgery videos, with a particular focus on manual small-incision cataract surgery (SICS), a widely used surgical technique in low- and middle-income countries. We have established a research programme combining ophthalmic surgical expertise with advanced machine learning and computer vision.
Among our contributions are the development and public release of the SICS-105 and SICS-155 surgical video datasets and the organization of an international surgical phase recognition challenge at MICCAI 2025. Using these datasets, we have developed and evaluated deep learning approaches for automated recognition of surgical phases. Our work on SICS-155, published in Medical Image Analysis, demonstrated accurate recognition of 19 distinct surgical phases.
Building on these achievements, our current research focuses on surgical instrument segmentation, interpretable assessment of surgical performance, automated identification of intraoperative complications, and prediction of early postoperative outcomes. Our long-term objective is to translate these technologies into practical tools for surgical training, quality assurance, and improved patient safety, particularly in healthcare systems with limited resources.

since 07/2023

Research group leader and Senior Researcher in Ophthalmology,

University Hospital Bonn

10/2022

Fellow of the European Board of Ophthalmology (FEBO)

since 06/2022

University lecturer in Ophthalmology (Privatdozent)

Bonn University

06/2022

Habilitation (highest German university degree) in Ophthalmology

at the University of Bonn, Germany

Habilitation thesis: „Evaluation of Smartphone-based fundus imaging

for ophthalmologic examination”

04/2021 - 06/2023

Consultant Ophthalmologist

University Hospital Bonn

Clinical focus: retina and uveitis, cataract and vitreoretinal surgery

Since 02/2019

Director Hospital Partnership University Hospital Bonn - Sankara

Eye Hospital Bangalore, India

2017

Dissertation (Dr. med.): summa cum laude (with highest honor)

2015 - 2021

Resident in Ophthalmology

University Hospital Bonn (Prof. Dr. med. Frank G. Holz)

2010 - 2015

Medical Degree (M.D.), German state examination: 1.0 (top grade)

Ludwig-Maximilians-Universität (LMU) Munich, Germany

University of Cincinnati, USA

Weill Cornell Medical College New York, USA

2011 - 2013

Doctoral studies within the academic course „Molecular medicine”, LMU Munich

2008 - 2010

Preclinical studies: German state examination: 1.0 (top grade) LMU Munich and Technical University of Munich, Germany

Priv.-Doz. Dr. med. Maximilian W. M. Wintergerst, MD, FEBO (group leader)

Dr. med. Marie Just, MD

Raphael Lechtenböhmer, MD

Julie Jungblut, MD

Simon Jansen, MD

Simon Müller, M.Sc. in Computer Science

Freya Behrens, B.Sc. (Master student, WHF)

Johanna Heidel (medical student, SHK)

Selina Foti, B.Sc. (Master student, WHF)

Alexandra Weigandt (medical PhD student)

Finn V. Hille (medical PhD student)

Lucas P. Reindl (medical PhD student)

Lotta Sander (medical PhD student)

Kaja Scheel (medical PhD student)

Former members:

Gabriela Guzman (Master student, WHF)

Ilkin Yunuszada, MD

Markus Zeller, MD

Lennart Overbeck, MD

Jana Katharina Koch, MD

Dr. med. Nicholas Merten, MD

Dr. med. Linus Jansen, MD

93 publications in peer-reviewed Journals (including Progress in Retinal and Eye Research, Ophthalmology, American Journal of Ophthalmology, Ophthalmology Science, Medical Image Analysis, Scientific Reports, IOVS), thereof 37 first- / last-authorships. H-index: 26.

All Publications:

PubMed

Google Scholar

 

Selected Publications

Global Eye Care & Telemedicine

Lechtenboehmer R, et al. (2026). Smartphone-based fundus imaging in global eye care: Closing the gap. Progress in Retinal and Eye Research. JIF: 16.2
https://doi.org/10.1016/j.preteyeres.2026.101515

Jansen LG, et al. (2021). Learning curve evaluation upskilling retinal imaging using smartphones. Scientific Reports, 11, 12691. JIF: 5.0
https://doi.org/10.1038/s41598-021-92232-w

Wintergerst MWM, et al. (2020). Diabetic Retinopathy Screening Using Smartphone-Based Fundus Imaging in India. Ophthalmology, 127(11), 1529–1538. JIF: 12.1
https://doi.org/10.1016/j.ophtha.2020.05.025

Wintergerst MWM, et al. (2019). Non-contact smartphone-based fundus imaging compared to conventional fundus imaging: a low-cost alternative for retinopathy of prematurity screening and documentation. Scientific Reports, 9, 19711. JIF: 4.0
https://doi.org/10.1038/s41598-019-56155-x

Artificial Intelligence in Cataract Surgery

Mueller S, et al. (2027). Advancing automated phase recognition in cataract surgery through the SICS-155 challenge. Medical Image Analysis, 115, 104313. Published online September 2026. JIF: 14.0
https://doi.org/10.1016/j.media.2026.104313

Mueller S, et al. (2025). Phase recognition in manual Small-Incision cataract surgery with MS-TCN++ on the novel SICS-105 dataset. Scientific Reports, 15, 16886. JIF: 3.8
https://doi.org/10.1038/s41598-025-00303-z

Müller S, et al. (2024). Artificial Intelligence in Cataract Surgery: A Systematic Review. Translational Vision Science & Technology, 13(4), 20. JIF: 3.0
https://doi.org/10.1167/tvst.13.4.20

Innovative Imaging & Uveitis

Just MD, et al. (2026). Reliability of quantitative and qualitative chorioretinal uveitis lesion analysis on blue, green, and near-infrared fundus autofluorescence and color fundus photography. Scientific Reports, 16, 16815. JIF: 4.9
https://doi.org/10.1038/s41598-026-54450-y

Wintergerst MWM, et al. (2024). Vessel density on optical coherence tomography angiography is prognostic for future disease course in intermediate uveitis. Scientific Reports, 14, 2933. JIF: 3.9
https://doi.org/10.1038/s41598-023-49926-0

Wintergerst MWM, et al. (2021). Structural Endpoints and Outcome Measures in Uveitis. Ophthalmologica, 244(5), 465–479. JIF: 3.8
https://doi.org/10.1159/000517521

Wintergerst MWM, et al. (2018). Optical Coherence Tomography Angiography in Intermediate Uveitis. American Journal of Ophthalmology, 194, 35–45. JIF: 4.5
https://doi.org/10.1016/j.ajo.2018.06.023

 
Unsere Webseite verwendet Cookies.

Bei Cookies handelt es sich um Textdateien, die im Internetbrowser bzw. vom Internetbrowser auf dem Computersystem des Nutzers gespeichert werden. Ruft ein Nutzer eine Website auf, so kann ein Cookie auf dem Betriebssystem des Nutzers gespeichert werden. Dieser Cookie enthält eine charakteristische Zeichenfolge, die eine eindeutige Identifizierung des Browsers beim erneuten Aufrufen der Website ermöglicht. Wir setzen Cookies ein, um unsere Website nutzerfreundlicher zu gestalten. Einige Elemente unserer Internetseite erfordern es, dass der aufrufende Browser auch nach einem Seitenwechsel identifiziert werden kann.

Unsere Webseite verwendet Cookies.

Bei Cookies handelt es sich um Textdateien, die im Internetbrowser bzw. vom Internetbrowser auf dem Computersystem des Nutzers gespeichert werden. Ruft ein Nutzer eine Website auf, so kann ein Cookie auf dem Betriebssystem des Nutzers gespeichert werden. Dieser Cookie enthält eine charakteristische Zeichenfolge, die eine eindeutige Identifizierung des Browsers beim erneuten Aufrufen der Website ermöglicht. Wir setzen Cookies ein, um unsere Website nutzerfreundlicher zu gestalten. Einige Elemente unserer Internetseite erfordern es, dass der aufrufende Browser auch nach einem Seitenwechsel identifiziert werden kann.

Ihre Cookie-Einstellungen wurden gespeichert.